FOLFOX treatment response prediction in metastatic or recurrent colorectal cancer patients via machine learning algorithms

Early identification of metastatic or recurrent colorectal cancer (CRC) patients who will be sensitive to FOLFOX (5‐FU, leucovorin and oxaliplatin) therapy is very important. We performed microarray meta‐analysis to identify differentially expressed genes (DEGs) between FOLFOX responders and nonresp...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Med
Hlavní autoři: Lu, Wei, Fu, Dongliang, Kong, Xiangxing, Huang, Zhiheng, Hwang, Maxwell, Zhu, Yingshuang, Chen, Liubo, Jiang, Kai, Li, Xinlin, Wu, Yihua, Li, Jun, Yuan, Ying, Ding, Kefeng
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Clinical Cancer Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7013065/
https://ncbi.nlm.nih.gov/pubmed/31893575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2786
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky